An anti-neomycin antibody interfering with ABO grouping and antibody screening.
D000017:ABO Blood-Group System; D000617:Aminoglycosides / Q000276:immunology; D000667:Ampicillin / Q000627:therapeutic use; D000906:Antibodies / Q000032:analysis*; D002740:Chlorothiazide / Q000627:therapeutic use; D002848:Chromatography, DEAE-Cellulose; D002918:Chymotrypsin / Q000627:therapeutic use; D003298:Coombs Test; D003429:Cross Reactions; D003707:Demeclocycline / Q000627:therapeutic use; D004912:Erythrocytes / Q000276:immunology; D004967:Estrogens / Q000627:therapeutic use; D005260:Female; D006385:Hemagglutination Inhibition Tests; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007074:Immunoglobulin G / Q000032:analysis; D008623:Mercaptoethanol / Q000494:pharmacology; D008875:Middle Aged; D009355:Neomycin; D010406:Penicillins / Q000627:therapeutic use; D011655:Pulmonary Embolism / Q000188:drug therapy; D013924:Thrombophlebitis / Q000188:drug therapy; D014357:Trypsin / Q000627:therapeutic use; D014859:Warfarin / Q000627:therapeutic use
D000017:ABO Blood-Group System; D000617:Aminoglycosides; D000906:Antibodies; D004967:Estrogens; D007074:Immunoglobulin G; D010406:Penicillins; D014859:Warfarin; D003707:Demeclocycline; D008623:Mercaptoethanol; D002740:Chlorothiazide; D000667:Ampicillin; D006493:Heparin; D002918:Chymotrypsin; D014357:Trypsin; D009355:Neomycin